| Literature DB >> 22839355 |
Abstract
This is the annual perspective paper on the discontinued drugs in the field of pulmonary allergy, gastrointestinal, and arthritis conditions. It is part of series of papers discussing drugs discontinued from clinical development in the previous year and presented according to therapeutic indication. Specifically, this paper presents the 23 compounds developed for various inflammatory conditions and 10 pulmonary drugs which were discontinued in 2011. Information for this perspective was derived from a search of the Pharmaprojects database for drugs discontinued after reaching Phase-I - III clinical trials.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22839355 DOI: 10.1517/13543784.2012.712112
Source DB: PubMed Journal: Expert Opin Investig Drugs ISSN: 1354-3784 Impact factor: 6.206